172 related articles for article (PubMed ID: 17169840)
1. Application of FGF-2 to modulate herpetic stromal keratitis.
Kim B; Lee S; Kaistha SD; Rouse BT
Curr Eye Res; 2006 Dec; 31(12):1021-8. PubMed ID: 17169840
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
3. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
[TBL] [Abstract][Full Text] [Related]
4. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 2, heparin and suramin reduce epithelial ulcer development in experimental HSV-1 keratitis.
Rieck P; Denis J; Peters D; Hartmann C; Pouliquen Y; Courtois Y
Graefes Arch Clin Exp Ophthalmol; 1997 Nov; 235(11):733-40. PubMed ID: 9407232
[TBL] [Abstract][Full Text] [Related]
6. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
[TBL] [Abstract][Full Text] [Related]
7. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
[TBL] [Abstract][Full Text] [Related]
9. Topical antisense-oligonucleotides targeting IFN-gamma mRNA improve incidence and severity of herpetic stromal keratitis by cytokine specific and sequence unspecific effects.
Wasmuth S; Bauer D; Steuhl KP; Heiligenhaus A
Graefes Arch Clin Exp Ophthalmol; 2008 Mar; 246(3):443-51. PubMed ID: 18030487
[TBL] [Abstract][Full Text] [Related]
10. Study of a polymerase chain reaction-based method for detection of herpes simplex virus type 1 DNA among Iranian patients with ocular herpetic keratitis infection.
Khodadoost MA; Sabahi F; Behroz MJ; Roustai MH; Saderi H; Amini-Bavil-Olyaee S; Arzenani MK
Jpn J Ophthalmol; 2004; 48(4):328-32. PubMed ID: 15295656
[TBL] [Abstract][Full Text] [Related]
11. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus-specific T cells infiltrate the cornea of patients with herpetic stromal keratitis: no evidence for autoreactive T cells.
Verjans GM; Remeijer L; Mooy CM; Osterhaus AD
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2607-12. PubMed ID: 10937573
[TBL] [Abstract][Full Text] [Related]
14. Detection of herpes simplex virus DNA in tear fluid of stromal herpetic keratitis patients by nested polymerase chain reaction.
Kudo E; Shiota H; Kinouchi Y; Mimura Y; Itakura M
Jpn J Ophthalmol; 1996; 40(3):390-6. PubMed ID: 8988430
[TBL] [Abstract][Full Text] [Related]
15. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions.
Gangappa S; Deshpande SP; Rouse BT
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):453-9. PubMed ID: 10670475
[TBL] [Abstract][Full Text] [Related]
16. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
18. Topical use of rapamycin in herpetic stromal keratitis.
Zapata G; Racca L; Tau J; Berra A
Ocul Immunol Inflamm; 2012 Oct; 20(5):354-9. PubMed ID: 23030354
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
Komatsu K; Miyazaki D; Morohoshi K; Kuo CH; Kakimaru-Hasegawa A; Komatsu N; Namba S; Haino M; Matsushima K; Inoue Y
Curr Eye Res; 2008 Sep; 33(9):736-49. PubMed ID: 18798077
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
